185 related articles for article (PubMed ID: 21220493)
21. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
22. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
Tee AR; Pause A
Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
[TBL] [Abstract][Full Text] [Related]
23. Disruption of tubular Flcn expression as a mouse model for renal tumor induction.
Chen J; Huang D; Rubera I; Futami K; Wang P; Zickert P; Khoo SK; Dykema K; Zhao P; Petillo D; Cao B; Zhang Z; Si S; Schoen SR; Yang XJ; Zhou M; Xiao GQ; Wu G; Nordenskjöld M; Tauc M; Williams BO; Furge KA; Teh BT
Kidney Int; 2015 Nov; 88(5):1057-69. PubMed ID: 26083655
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
[TBL] [Abstract][Full Text] [Related]
25. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
26. A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.
Bandini E; Zampiga V; Cangini I; Ravegnani M; Arcangeli V; Rossi T; Mammi I; Schiavi F; Zovato S; Falcini F; Calistri D; Danesi R
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569793
[TBL] [Abstract][Full Text] [Related]
27. Human folliculin delays cell cycle progression through late S and G2/M-phases: effect of phosphorylation and tumor associated mutations.
Laviolette LA; Wilson J; Koller J; Neil C; Hulick P; Rejtar T; Karger B; Teh BT; Iliopoulos O
PLoS One; 2013; 8(7):e66775. PubMed ID: 23874397
[TBL] [Abstract][Full Text] [Related]
28. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
[TBL] [Abstract][Full Text] [Related]
29. PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis.
van de Beek I; Glykofridis IE; Oosterwijk JC; van den Akker PC; Diercks GFH; Bolling MC; Waisfisz Q; Mensenkamp AR; Balk JA; Zwart R; Postma AV; Meijers-Heijboer HEJ; van Moorselaar RJA; Wolthuis RMF; Houweling AC
Hum Mol Genet; 2023 Mar; 32(7):1223-1235. PubMed ID: 36440963
[TBL] [Abstract][Full Text] [Related]
30. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
Wu J; Lu J; Wu CL; Lu M
Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
[TBL] [Abstract][Full Text] [Related]
31. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
[TBL] [Abstract][Full Text] [Related]
33. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
34. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
Hasumi H; Hasumi Y; Baba M; Nishi H; Furuya M; Vocke CD; Lang M; Irie N; Esumi C; Merino MJ; Kawahara T; Isono Y; Makiyama K; Warner AC; Haines DC; Wei MH; Zbar B; Hagenau H; Feigenbaum L; Kondo K; Nakaigawa N; Yao M; Metwalli AR; Marston Linehan W; Schmidt LS
Hum Mol Genet; 2017 Jan; 26(2):354-366. PubMed ID: 28007907
[TBL] [Abstract][Full Text] [Related]
35. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
[TBL] [Abstract][Full Text] [Related]
36. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN.
Woodward ER; Ricketts C; Killick P; Gad S; Morris MR; Kavalier F; Hodgson SV; Giraud S; Bressac-de Paillerets B; Chapman C; Escudier B; Latif F; Richard S; Maher ER
Clin Cancer Res; 2008 Sep; 14(18):5925-30. PubMed ID: 18794106
[TBL] [Abstract][Full Text] [Related]
37. Expression and knockdown of zebrafish folliculin suggests requirement for embryonic brain morphogenesis.
Kenyon EJ; Luijten MN; Gill H; Li N; Rawlings M; Bull JC; Hadzhiev Y; van Steensel MA; Maher E; Mueller F
BMC Dev Biol; 2016 Jul; 16(1):23. PubMed ID: 27391801
[TBL] [Abstract][Full Text] [Related]
38. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
Furuya M; Nakatani Y
Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
[TBL] [Abstract][Full Text] [Related]
39. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
[TBL] [Abstract][Full Text] [Related]
40. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
Hasumi H; Baba M; Hasumi Y; Huang Y; Oh H; Hughes RM; Klein ME; Takikita S; Nagashima K; Schmidt LS; Linehan WM
J Natl Cancer Inst; 2012 Nov; 104(22):1750-64. PubMed ID: 23150719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
